Instituto de Diagnostico SA

Instituto de Diagnostico SA maintains a market price of 2700.0, with a market capitalization of 414,261,718,200.0. The company's price-to-earnings ratio is 26.45, and its price-to-book ratio is 2.0, indicating a moderate valuation relative to its book value. The enterprise value to EBITDA ratio is 14.26, and the enterprise value to revenue ratio is 1.83, suggesting a relatively low valuation in terms of revenue. The company's profitability is reflected in its return on equity of 7.56% and return on assets of 3.83%. These figures are compared against the industry's preferred metrics, indicating that the company is performing in line with or slightly below the median for its sector. The gross profit margin is 25.95%, and the operating margin is 12.85%, which are key indicators of the company's efficiency in converting revenue into profit. In terms of geographic and segment exposure, the company's revenue is primarily concentrated in its domestic market, with no significant international operations disclosed. The company operates as a single segment, and its revenue is not diversified across multiple geographic regions. This concentration may pose a risk if the domestic market experiences economic downturns. The company's growth trajectory is expected to remain stable, with no significant changes in revenue forecasted for the current and next fiscal years. The company's capital expenditure is negative, indicating that it is generating more cash from operations than it is spending on new assets. This suggests a conservative approach to capital spending and a focus on maintaining liquidity. The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk. The key flag of concern is the negative net cash position after subtracting total debt, which may affect the company's ability to meet short-term obligations. The company's debt-to-equity ratio is 0.48, and its current ratio is 1.18, indicating a moderate level of leverage and a relatively strong short-term liquidity position. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company has not issued any new shares recently, and there are no indications of upcoming dilutive events. The company's financial statements and disclosures are consistent with its historical performance, and there are no material risks disclosed in recent filings.